Inversion-based feed-forward compensation of inspiratory trigger dynamics in medical ventilators

Information

  • Patent Grant
  • 8794234
  • Patent Number
    8,794,234
  • Date Filed
    Thursday, September 24, 2009
    14 years ago
  • Date Issued
    Tuesday, August 5, 2014
    9 years ago
Abstract
A ventilator and method of ventilator control. The ventilator includes a pneumatic system for providing and receiving breathing gas, and a controller operatively coupled with the pneumatic system. The controller employs closed-loop control to provide positive breathing assistance to a patient. Supplemental feed-forward compensatory assistance is also provided, in addition to and independently of that commanded by the closed-loop control. The supplemental assistance may be determined, set or selected based on a ventilator parameter and/or an operator parameter, and/or as an automatic ongoing compensatory mechanism responding to varying patient respiratory demand.
Description
BACKGROUND

The present description pertains to ventilator devices used to provide breathing assistance. Modern ventilator technologies commonly employ positive pressure to assist patient-initiated inspiration (inhalation). For example, after detecting that the patient wants to inhale, the ventilator control systems track a reference trajectory to increase pressure in an inhalation airway connected to the patient, causing or assisting the patient's lungs to fill. The tracking fidelity of the generated pressure (compared against the desired reference trajectory) and timely delivery of demanded flow are important factors impacting patient-ventilator synchrony and patient's work of breathing. Upon reaching the end of the inspiration, the patient is allowed to passively exhale and the ventilator controls the gas flow through the system to maintain a designated airway pressure level (PEEP) during the exhalation phase.


Modern ventilators typically include microprocessors or other controllers that employ various control schemes. These control schemes are used to command a pneumatic system (e.g., valves) that regulates the flow rates of breathing gases to and from the patient. Closed-loop control is often employed, using data from pressure/flow sensors.


Generally, it is desirable that the control methodology cause a timely response to closely match the desired quantitative and timing requirements of the operator-set ventilation assistance. However, a wide range of variables can significantly affect the way ventilator components respond to commands issued from the controller to generate the intended pressure waveform. For example, the compliance of the patient breathing circuit, the mechanical and transient characteristics of pneumatic valves, the resistance of the circuit to gas flow, etc. and patient's breathing behavior can cause significant variation or delays in the resulting pressure/flow waveforms compared to the desired reference. Furthermore, even when very specific situational information is available (e.g., concerning patient and device characteristics), existing control systems are often sub-optimal in leveraging this information to improve ventilator performance.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic depiction of a ventilator.



FIG. 2 schematically depicts control systems and methods that may be employed with the ventilator of FIG. 1.



FIG. 3 schematically depicts an exemplary lumped parameter model which may be used to derive supplemental control commands shown in FIGS. 4B, 4C and 4D.



FIGS. 4A-4D depict exemplary tidal breathing in a patient, and examples of control commands which may be employed in a ventilator to assist tidal breathing with inspiratory pressure support.



FIG. 5 depicts a touch-sensitive display interface that may be used with the ventilator of FIG. 1.





DETAILED DESCRIPTION


FIG. 1 depicts a ventilator 20 according to the present description. As will be described in detail, the various ventilator embodiments described herein may be provided with improved control schemes. These control schemes typically enhance closed-loop control performance, and may be operator-selected to account for specific factors relating to the device, patient and/or use setting. When implemented for spontaneous breathing, the control methodologies normally command a specified ventilatory support following detection of patient inspiratory effort. This compensatory support is in addition to that commanded by the primary closed-loop control system, and its application improves response time, patient-ventilator synchrony and other aspects of system performance. The compensatory support is (model) inversion-based and computed from known and/or estimated hardware and/or patient characteristics model(s) and measured parameters of breathing behavior. After determination of the quantity and temporal waveform of the compensation, it is delivered by feedforward mechanism as an added component to the desired signal reference trajectory generated by the ventilator's closed-loop controller. Also, it is envisioned that a compensatory mechanism could be designed based on the same concept and adapted as a transitory augmentation to the actuator command. The present discussion will focus on specific example embodiments, though it should be appreciated that the present systems and methods are applicable to a wide variety of ventilatory devices.


Referring now specifically to FIG. 1, ventilator 20 includes a pneumatic system 22 for circulating breathing gases to and from patient 24 via airway 26, which couples the patient to the pneumatic system via physical patient interface 28 and breathing circuit 30. Breathing circuit 30 typically is a two-limb circuit having an inspiratory limb 32 for carrying gas to the patient, and an expiratory limb 34 for carrying gas from the patient. A wye fitting 36 may be provided as shown to couple the patient interface to the two branches of the breathing circuit. The present description contemplates that the patient interface may be invasive or non-invasive, and of any configuration suitable for communicating a flow of breathing gas from the patient circuit to an airway of the patient. Examples of suitable patient interface devices include a nasal mask, nasal/oral mask (which is shown in FIG. 1), nasal prong, full-face mask, tracheal tube, endotracheal tube, nasal pillow, etc.


Pneumatic system 22 may be configured in a variety of ways. In the present example, system 22 includes an expiratory module 40 coupled with expiratory limb 34 and an inspiratory module 42 coupled with inspiratory limb 32. Compressor 44 is coupled with inspiratory module 42 to provide a gas source for controlled ventilatory support via inspiratory limb 32.


The pneumatic system may include a variety of other components, including air/oxygen supply sources, mixing modules, valves, sensors, tubing, accumulators, filters, etc.


Controller 50 is operatively coupled with pneumatic system 22, and an operator interface 52 may be provided to enable an operator to interact with the ventilator (e.g., change ventilator settings, select operational modes, view monitored parameters, etc.). Controller 50 may include memory 54, one or more processors 56, storage 58, and/or other components of the type commonly found in measurement, computing, and command and control devices. As described in more detail below, controller 50 issues commands to pneumatic system 22 in order to control the breathing assistance provided to the patient by the ventilator. The specific commands may be based on inputs sensed/received from patient 24, pneumatic system 22 including transducers and data acquisition modules, operator interface 52 and/or other components of the ventilator. In the depicted example, operator interface includes a display 59 that is touch-sensitive, enabling the display to serve both as an input and output device.



FIG. 2 schematically depicts exemplary systems and methods of ventilator control. As shown, controller 50 issues control commands 60 to ultimately drive pneumatic system 22 and thereby regulate circulation (delivery and exhaust) of breathing gas to and from patient 24. The command(s) 60 to the Flow Controller 71 and ultimately to the pneumatic system actuator(s) to regulate flow rates of different gases such as air and/or oxygen (as applicable based on set mix ratio) is (are) calculated and combined based on two methods: closed-loop control of the output signal and inversion-based compensatory feedforward. For example, in the case of a spontaneously breathing patient on Pressure Support, the closed-loop control system may be envisioned to consist of a closed-loop pressure controller in cascade with closed-loop flow controller 71 (more than one flow controller in cases when flow rates of more than one gas need to be regulated). In this example, at every control cycle (e.g., every 5 ms) the closed-loop pressure controller computes a flow rate command based on the measured pressure error derived from a comparison against the desired pressure trajectory. The Supplemental Controller 50, under this example, utilizes an inversion-based method to compute from known and/or estimated hardware models (breathing circuit resistance and compliance, actuator dead bands and delays, etc.) and/or patient characteristics (respiratory resistance and compliance) or measured parameters of breathing behavior (e.g., estimated pressure drop caused by patient inspiratory effort), or controller delays to determine the quantity and temporal waveform of the compensation and calculates the corresponding command (in this example, the supplemental flow rate) for each control cycle. In this example, the additional (flow) command is added to the desired flow reference command generated by the pressure controller. The combined Supplemental flow command 60b and pressure Controller flow command 60a constitutes the reference input 60 to the flow controller 71. In general, in the case of Pressure Support, the closed-loop controller may be designed in different ways and as an example it could consist of a single pressure controller combined with a mix controller that closes the loop on the measured pressure signal. In this case or other closed-loop control design variations, the nature of the compensatory feedforward supplement would be determined in compliance with the physical units of the resulting command.



FIG. 3 represents a simplified lumped-parameter analog model 81 for patient circuit and single-compartment respiratory system. Patient circuit is represented by resistance Rt 82 and compliance Ct 84. The patient's respiratory dynamics are captured by total respiratory resistance Rp 86, total respiratory compliance Cp 88, and patient-generated muscle pressure Pmus 90. Using this model, the time response of the airway pressure Paw 92 is a function of patient muscle pressure Pmus 90 and lung flow Qp 94 subsequent to ventilator output flow Qv 96 as determined and delivered by a ventilator 98 command and control subsystems and ventilator-patient interactive characteristics. In patient-initiated triggering, the airway pressure drops below the baseline and lung flow increases concomitantly as a result of the patient's inspiratory effort and the negative pressure generated in the lung. The current embodiment may employ this model as the inversion mechanism to compute an optimum additional volume of gas to be feed-forward as a supplement to the flow rates determined by the closed-loop controller. The additional volume will be commanded independent of the closed-loop pressure regulation controller and delivered in accordance with a specified flow time trajectory. During the patient triggering process, the pressure drop generated by the patient effort will be indicated by a corresponding pressure drop at the patient wye and increasing flow into the lung. To bring back the lung pressure to the baseline level at the initial phase of an inspiration, one way to compute the volume of gas required to be added into the lung would be to estimate the lung pressure,

Plung=Paw−Rp*Qp,

then, calculate the drop from baseline, and finally compute the additional volume using a given or an estimated value for lung compliance:

ΔV=ΔP*Cp

In this example, the proposed algorithmic process may consist of two basic steps:


1. The wye (proximal patient-circuit interface) pressure and lung flow waveforms during the triggering process leading to the ventilator's successful transition into inspiration may be used in conjunction with the estimated ventilator-plant parameters (including actuator and controller time delays and patient respiratory mechanics) and patient comfort considerations to compute an optimum gas volume to be supplemented as an added flow rate over time to the flow determined by the closed-loop controller(s). The feedforward flow is intended to enhance more effective pressure recovery to the designated baseline and thus minimizing the patient's triggering work of breathing and enhancing comfort.


2. The compensatory volume will be commanded independent of the closed-loop pressure regulation controller and delivered in accordance with a specified flow time trajectory. This trajectory will consist of two sections: an initial step of amplitude (Qaddmax) and duration Tstep 76 initiated immediately after trigger detection and followed by a final exponential drop from Qaddmax plateau to zero by a specified time constant Tauexp 78, shown in FIGS. 4B-4D. These parameters may be set adaptively based on patient breathing behavior and ventilator performance or optimum fixed values could be determined to enable satisfactory performance for each patient type. The ultimate goal would be to minimize the work or triggering, minimize tracking error, and ensure patient comfort and patient-ventilator synchrony.


The depicted schematic interaction between pneumatic system 22 and patient 24, as shown in FIG. 1 and FIG. 2, may be viewed in terms of pressure or flow “signals.” For example, signal 62 may be an increased pressure which is applied to the patient via inspiratory limb 32. Control commands 60 are based upon inputs received at controller 50 which may include, among other things, inputs from operator interface 52, and feedback from pneumatic system 22 (e.g., from pressure/flow sensors) and/or sensed from patient 24.


Controller 50, as shown in FIG. 1 and FIG. 2, may be configured to implement a wide variety of control methodologies, though the present examples have proved particularly useful in the context of patient-triggered pressure-based ventilation. In particular, ventilator 20 is adapted to detect inspiratory efforts of patient 24, and respond by delivering positive pressure to assist the breathing effort. Magnitude, timing and other characteristics of the positive pressure assist may be controlled in response to feedback received from the device (e.g., user interface 59, pneumatic system 22) or patient 24. In many cases, patient feedback is inferred from device data. For example, a relatively rapid pressure drop at the patient interface 36 may be used to infer an inspiratory patient effort. The magnitude of this pressure drop together with patient's respiratory mechanics parameters (given or estimated) and breathing circuit characteristics could be used to estimate the gas volume required to be added into the lung to bring back the lung pressure to the baseline.


Ventilator control may be further understood with reference to FIG. 4A-4D. FIG. 4A shows several cycles of typical tidal breathing, in terms of lung flow and airway pressure. As discussed above, a patient may have difficulty achieving normal tidal breathing, due to illness or other factors. In some cases, normal lung volumes may be achieved without mechanical ventilation, but only with debilitating effort that can impede healing or cause further physiological damage. In other cases, disease factors prevent the patient from achieving tidal volumes without assistance.


Regardless of the particular cause or nature of the underlying condition, ventilator 20 typically provides breathing assistance via positive pressure during inspiration. FIGS. 4B-4D show example control signal waveforms, to be explained in more detail below, that may be used to drive pneumatic system 22 to deliver the desired pressure support. In many cases, the goal of the control system is to deliver a controlled pressure profile or trajectory (e.g., pressure as a function of time) during the inspiratory or expiratory phases of the breathing cycle. In other words, control is performed to achieve a desired time-varying pressure output 62 from pneumatic system 22, with an eye toward achieving or aiding breathing.


As shown in FIG. 2, controller 50 includes a primary controller 70, also referred to as the “feedback” controller, that generates command 60a intended to target the desired reference trajectory, and a supplemental controller 72 to augment the closed loop control with command 60b and proactively compensate for system latencies caused by multiple factors as discussed above. The compensatory quantity and its temporal delivery characteristics are determined based on specific operational settings, to enhance patient-ventilator synchrony and control system dynamic effectiveness.


For a given respiratory therapy, the treatment goal is often set in terms of the timing and amount of increased pressure and gas mixture delivered to the patient during inspiration and maintenance of a set airway pressure during exhalation. Accordingly, a design focus of the control system should be to quickly and accurately detect the beginning of the patient's attempted inspiration, and then have the mechanical system rapidly respond to track the desired pressure trajectory with optimum fidelity.


As shown in FIG. 2, controller 70 is designed to provide such closed-loop control. In particular, controller 50 detects airway pressure (e.g., via feedback signal F) drop from baseline (Pressure Triggering mechanism) or increased lung flow (Flow Triggering mechanism) to establish initiation of inspiratory support. Closed-loop controller 70 and supplemental controller 72 then work in concert to command pneumatic system 22 to provide the desired inspiratory signal trajectory.


As will be described in more detail below, the provision of a supplemental control enables the operator of the ventilator to more accurately account and compensate for various factors affecting system dynamics in a more timely fashion. For example, pneumatic system 22 contains many components that can significantly affect the response produced by a given control command, such as command 60a. Further, the patient constitutes a major variable whose time-varying and hard-to-predict breathing behavior is unknown to typical ventilator closed-loop controllers and would cause variations and latencies in the controller's tracking performance.


In particular, pneumatic system 22 typically includes multiple modules, each having various components. Valve characteristics, the geometry and compliance of pneumatic passages, conduit resistance to gas flow, actuator/controller time delays, humidifier parameters, filter types and a host of other factors can affect system dynamics. In particular, these components can create variable lags, such that the pressure in inspiratory limb 32 may rise more slowly than desired. This lagging of the desired trajectory would require the patient to do more breathing work during inspiration, and thereby may negatively impact treatment.


A number of patient characteristics and breathing behavior can also affect the system's dynamic performance. The patient characteristics may define or describe physiological traits of the patient, including respiratory musculature, baseline or expected respiratory performance, height, weight, specific disease/illness indications, age, sex, etc.


Closed-loop controller 70 may employ various control schemes, and typically is designed to command the output to a desired value or trajectory without addition of any model-based feedforward supplemental control regimes computed based on the inversion of the ventilator-patient model under ongoing dynamic conditions using available measurements. However, due to the nature of the closed loop control and the potential wide variation in device and patient characteristics, signal 60a may produce sub-optimal pressure response and/or patient-device synchrony. Accordingly, supplemental controller 72 may provide an additional command signal 60b to substantially decrease the patient work effort during inspiration, allowing the breathing assistance provided by the ventilator to be properly synchronized with the patient initiated breathing cycle. As one example, command signal 60b may be generated using a feed-forward predictive model, to be discussed in more detail herein, which leverages a richer data set concerning the device and/or patient to fine tune ventilator performance.


Indeed, command signal 60b may take into account plant parameters, such as delays caused by ventilator components, and/or patient parameters affecting system transfer functions. In this way proper triggering can occur and the performance of the overall pneumatic system can be better synchronized with the respiratory cycle of the patient. Signal 60b typically is not intended to be used as the primary control strategy. Rather, it provides an additional feed-forward input to minimize delays and otherwise fine tune controller tracking fidelity during inspiration. Because the supplementary command acts as an adjunct to the primary closed-loop controller, instead of replacing it, the primary closed-loop feature would protect against delivery of excessively high commands. In other words, even though the added control is feed-forward and independent of the closed-loop controller, the ultimate output flow to the patient is regulated by the closed-loop regime, i.e., at every control cycle (e.g., 5 ms), the contribution of the feedback controller to the total command would be promptly reduced in case of output deviation caused by the supplemental command.



FIGS. 4B, 4C and 4D show exemplary control waveforms that may be provided by the supplemental feed-forward controller 72. The different supplemental waveforms 60b1, 60b2 and 60b3 are alternatives that may be selected for different circumstances. In other words, supplemental command 60b1 might be applied in a first operational environment, with supplemental command 60b2 being used in a different operational environment, for example on a patient with a different breathing characteristic or type of illness (when available). In each of the three examples, the supplemental command is provided rapidly upon detection of the trigger (patient initiates in-breath), and the signal waveform may be described in terms of three aspects. The first aspect is gain or rise 74. The gain may be a simple step-up to the maximum flow rate Qmax, as shown in FIG. 4B and FIG. 4C. In another example, the gain may occur over time, as shown in FIG. 4D. Accordingly, the gain may be described in terms of magnitude Qmax and time. The second aspect, Tstep 76, is the amount of time over which Qmax is delivered. A third aspect is the exponential decay trajectory time constant Tauexp 78.


These control signal aspects may be modified as necessary to achieve control design and ultimately treatment objectives. In one example, the patient may periodically generate a larger inspiratory effort and demand an increased tidal volume and duration of the breathing cycle. To account for these variations, Qmax and Tstep, or Tauexp may be adjusted accordingly. Alternatively, the shape of the waveform generated by the supplemental controller 72 may be trapezoidal, sawtooth or have other forms. The specific waveform 60b1, 60b2, 60b3 (or others) typically is selected based on desired output of the system and to account for device and patient characteristics.


The systems and methods described herein may employ this model as an inversion mechanism to compute an optimum additional volume of gas to be feed-forward as a supplement to the flow rates commanded by the primary controller 70. As further described herein, the additional volumes are determined independently of the closed-loop pressure regulation controller (controller 70) and in accordance with a specified flow time trajectory (see supplemental commands 60b1, 60b2, etc.)


The values of the various lumped-parameters may be calculated based on data associated with the ventilator device, patient, operational setting, and ongoing pressure and flow measurements, etc. For example, inputs into operator interface 52 may be used to set values for the lumped parameters. Then, during operation of the ventilator, the supplemental controller calculates compensatory regimes to be feed-forward and commanded by the primary flow controller 71.


In other examples, the model may be expanded to include additional components to model further aspects of the patient-ventilator system. Alternatively, other types of predictive modeling may be used to synchronize the ventilator with the patient's breathing cycle and improve system response.


As shown in FIG. 4, the control enhancement provided by supplemental controller 72 may take various forms. For example, commands 60b may be selected differently in order to provide different pressure trajectory enhancements, such as faster rise time, pressure boosts of varying magnitude/duration, etc. In various example embodiments, ventilator 20 may be configured to allow an operator to select control enhancement via interaction with operator interface 52. For example, selection of a first parameter or parameter combination might cause controller 72 to produce commands 60b1, while a second parameter/combination might produce commands 60b2 and so on.



FIG. 5 schematically depicts an exemplary interface scheme for selecting various parameters to control operation of supplemental controller 72. The depicted exemplary scheme may be applied to the controller through various input/interface mechanisms, including through use of operator interface 52. For example, touch-sensitive display 59 may include a high-level menu option, as indicated, for entering a portion of the interface where specific supplemental control parameters can be selected. As indicated, the operator may be permitted to select ventilator/device parameters and/or parameters associated with the patient. As indicated ventilator/device parameters may include type of patient interface; etc. Patient parameters may include information concerning respiratory dynamics; respiration rates; patient physiological data; specification of whether the patient is adult, pediatric, neonatal, etc.; whether disease factors A, B and/or C, etc. are present. These are but a few of the many possible parameters that can be selected (e.g., by an operator) or estimated online by the ventilator to tune the feed-forward trajectories commanded by supplemental controller 72. The main parameters to consider in conjunction with the lumped-parameter model are: tubing characteristics (resistance, compliance), patient respiratory mechanics (resistance, compliance), actuator dead bands and controller delays.


A variety of advantages may be obtained through use of the exemplary control systems and methods described herein. Respiratory therapy can be effectively improved through provision of the independent enhanced controller 72, because it provides an operator tunable and/or patient-interactive model-based mechanism for enriching the parameter set used to control the ventilatory assistance. In particular, a multitude of additional ventilator and patient variables may be selected to tune the controller and improve the fidelity with which the system tracks the desired output trajectory. The resulting speed and fidelity improvements lead to better synchrony of the device with the patient's spontaneous breathing operation, a key measure of ventilator performance. Furthermore, since the primary closed-loop control system still constrains system output, integration of the enhanced supplemental control typically will not pose system overshoot or stability problems.


It will be appreciated that the embodiments and method implementations disclosed herein are exemplary in nature, and that these specific examples are not to be considered in a limiting sense, because numerous variations are possible. The subject matter of the present disclosure includes all novel and nonobvious combinations and subcombinations of the various configurations and method implementations, and other features, functions, and/or properties disclosed herein. Claims may be presented that particularly point out certain combinations and sub combinations regarded as novel and nonobvious. Such claims may refer to “an” element or “a first” element or the equivalent thereof. Such claims should be understood to include incorporation of one or more such elements, neither requiring nor excluding two or more such elements. Other combinations and subcombinations of the disclosed features, functions, elements, and/or properties may be claimed through amendment of the present claims or through presentation of new claims in this or a related application. Such claims, whether broader, narrower, equal, or different in scope to the original claims, also are regarded as included within the subject matter of the present disclosure.

Claims
  • 1. A ventilator, comprising: a pneumatic system for providing and receiving breathing gas;a controller operatively coupled with the pneumatic system; andan operator interface, where the controller is operable to:execute a control scheme to command the pneumatic system to provide breathing gas to a patient during inspiration, where such breathing gas is provided in response to the ventilator detecting that the patient is attempting to initiate inspiration; andcommand delivery of a feed-forward input of additional breathing gas corresponding to a desired boost pressure waveform to the patient during inspiration, where the feed-forward input is commanded in response to operator selection of at least one of a ventilator parameter and a patient parameter at the operator interface, and where the desired boost pressure waveform is continuously modeled based on performance measurements of the control scheme by adjusting a gain and at least one of an amount of time required to deliver a maximum flow and an exponential decay trajectory time constant.
  • 2. The ventilator of claim 1, where the patient parameter enables specification of patient age.
  • 3. The ventilator of claim 2, where the patient parameter enables specification that the patient is an adult patient.
  • 4. The ventilator of claim 2, where the patient parameter enables specification that the patient is a pediatric patient.
  • 5. The ventilator of claim 2, where the patient parameter enables specification that the patient is a neonatal patient.
  • 6. The ventilator of claim 1, where the patient parameter enables specification of a patient disease condition.
  • 7. The ventilator of claim 1, where the patient parameter enables specification of a physiological characteristic of the patient.
  • 8. The ventilator of claim 1, where the ventilator parameter enables specification of characteristics of airway components used to couple the patient to the pneumatic system.
  • 9. The ventilator of claim 1, where the ventilator parameter enables specification of characteristics of the pneumatic system.
  • 10. A ventilator, comprising: a pneumatic system for providing and receiving breathing gas; anda controller operatively coupled with the pneumatic system, where the controller is operable to:execute a control scheme to command the pneumatic system to provide breathing gas to a patient during inspiration;receive a baseline closed-loop input corresponding to a desired output pressure of breathing gas from the pneumatic system;receive an additional feed-forward input corresponding to a desired boost pressure waveform to be added to the desired output pressure, the additional feed-forward input being dependent upon at least one of an operator-selected ventilator parameter and an operator-selected patient parameter;detect patient initiation of an inspiratory phase of a respiration cycle; andduring the inspiratory phase, command the pneumatic system to provide breathing gas based on the closed-loop input and the additional feed-forward input, the breathing gas being constrained through application of a feedback signal to the controller, where the desired boost pressure waveform is continuously modeled based on performance measurements of the control scheme by adjusting a gain and at least one of an amount of time required to deliver a maximum flow and an exponential decay trajectory time constant.
  • 11. The ventilator of claim 10, further comprising an operator interface operatively coupled with the controller and configured to enable an operator to select at least one ventilator parameter and patient parameter.
  • 12. The ventilator of claim 10, further comprising a patient breathing circuit and a physical patient interface configured to couple a patient to the pneumatic system.
  • 13. The ventilator of claim 10, where the patient parameter includes specification of patient age.
  • 14. The ventilator of claim 13, where the patient parameter includes specification that the patient is an adult patient.
  • 15. The ventilator of claim 13, where the patient parameter includes specification that the patient is a pediatric patient.
  • 16. The ventilator of claim 13, where the patient parameter includes specification that the patient is a neonatal patient.
  • 17. The ventilator of claim 10, where the patient parameter includes specification of a patient disease condition.
  • 18. The ventilator of claim 10, where the patient parameter includes specification of a physiological characteristic of the patient.
  • 19. The ventilator of claim 10, where the ventilator parameter includes specification of characteristics of airway components used to fluidly couple the patient to the pneumatic system.
  • 20. The ventilator of claim 10, where the ventilator parameter includes specification of characteristics of the pneumatic system.
  • 21. A method of operating a patient-triggered, positive pressure ventilator, comprising: driving a pneumatic system of the ventilator with a closed-loop control regime to provide positive pressure breathing assistance during inspiration;providing a supplemental added pressure boost corresponding to a desired boost pressure waveform during inspiration in addition to the breathing assistance commanded by the closed-loop control regime; andsetting the supplemental added pressure boost based on operator input of at least one of a ventilator parameter and a patient parameter, where the desired boost pressure waveform is continuously modeled based on performance measurements of the closed-loop control regime by adjusting a gain and at least one of an amount of time required to deliver a maximum flow and an exponential decay trajectory time constant.
  • 22. The method of claim 21, where the supplemental added pressure boost is applied during each of a plurality of respiration cycles, subsequent to patient-triggering of inspiration.
  • 23. The method of claim 21, where the supplemental added pressure boost is tunable from one therapy session to the next, such that in a first therapy session, the positive pressure breathing assistance supplied by the closed loop-control regime is supplemented with a first supplemental added pressure boost, while during a second therapy session, the positive pressure breathing assistance supplied by the closed loop-control regime is supplemented with a second supplemental added pressure boost which is different from the first, such difference being based on a change in at least one of the ventilator parameter and the patient parameter.
RELATED APPLICATION

This application claims the benefit of U.S. Provisional Application No. 61/100,212 filed Sep. 25, 2008, which application is hereby incorporated herein by reference.

US Referenced Citations (359)
Number Name Date Kind
4752089 Carter Jun 1988 A
4921642 LaTorraca May 1990 A
4954799 Kumar Sep 1990 A
5025806 Palmer et al. Jun 1991 A
5052386 Fischer, Jr. Oct 1991 A
5057822 Hoffman Oct 1991 A
5072737 Goulding Dec 1991 A
5103814 Maher Apr 1992 A
5150291 Cummings et al. Sep 1992 A
5161525 Kimm et al. Nov 1992 A
5165397 Arp Nov 1992 A
5237987 Anderson et al. Aug 1993 A
5271389 Isaza et al. Dec 1993 A
5279288 Christopher Jan 1994 A
5279549 Ranford Jan 1994 A
5299568 Forare et al. Apr 1994 A
5301921 Kumar Apr 1994 A
5307794 Rauterkus et al. May 1994 A
5316009 Yamada May 1994 A
5319540 Isaza et al. Jun 1994 A
5325861 Goulding Jul 1994 A
5333606 Schneider et al. Aug 1994 A
5339807 Carter Aug 1994 A
5343857 Schneider et al. Sep 1994 A
5351522 Lura Oct 1994 A
5357946 Kee et al. Oct 1994 A
5368019 Latorraca Nov 1994 A
5372126 Blau Dec 1994 A
5383449 Forare et al. Jan 1995 A
5385142 Brady et al. Jan 1995 A
5390666 Kimm et al. Feb 1995 A
5394892 Kenny et al. Mar 1995 A
5401135 Stoen et al. Mar 1995 A
5402796 Packer et al. Apr 1995 A
5407174 Kumar Apr 1995 A
5413110 Cummings et al. May 1995 A
5419314 Christopher May 1995 A
5433193 Sanders et al. Jul 1995 A
5437272 Fuhrman Aug 1995 A
5438980 Phillips Aug 1995 A
5443075 Holscher Aug 1995 A
5513631 McWilliams May 1996 A
5515844 Christopher May 1996 A
5517983 Deighan et al. May 1996 A
5520071 Jones May 1996 A
5524615 Power Jun 1996 A
5531221 Power Jul 1996 A
5540225 Schutt Jul 1996 A
5540233 Larsson et al. Jul 1996 A
5542415 Brady Aug 1996 A
5544674 Kelly Aug 1996 A
5549106 Gruenke et al. Aug 1996 A
5590651 Shaffer et al. Jan 1997 A
5596984 O'Mahoney et al. Jan 1997 A
5626151 Linden May 1997 A
5630411 Holscher May 1997 A
5632269 Zdrojkowski May 1997 A
5632270 O'Mahoney et al. May 1997 A
5645048 Brodsky et al. Jul 1997 A
5660171 Kimm et al. Aug 1997 A
5664560 Merrick et al. Sep 1997 A
5664562 Bourdon Sep 1997 A
5671767 Kelly Sep 1997 A
5672041 Ringdahl et al. Sep 1997 A
5673689 Power Oct 1997 A
5676133 Hickle et al. Oct 1997 A
5694926 DeVries et al. Dec 1997 A
5711294 Kee et al. Jan 1998 A
5715812 Deighan et al. Feb 1998 A
5752509 Lachmann et al. May 1998 A
5762480 Adahan Jun 1998 A
5771884 Yarnall et al. Jun 1998 A
5775325 Russo Jul 1998 A
5791339 Winter Aug 1998 A
5794986 Gansel et al. Aug 1998 A
5803065 Zdrojkowski et al. Sep 1998 A
5813399 Isaza et al. Sep 1998 A
5819723 Joseph Oct 1998 A
5820560 Sinderby et al. Oct 1998 A
5826575 Lall Oct 1998 A
5829428 Walters et al. Nov 1998 A
5829441 Kidd et al. Nov 1998 A
5830185 Block, Jr. Nov 1998 A
5848974 Cheng et al. Dec 1998 A
5864938 Gansel et al. Feb 1999 A
5865168 Isaza Feb 1999 A
5868133 DeVries et al. Feb 1999 A
5881717 Isaza Mar 1999 A
5881722 DeVries et al. Mar 1999 A
5881723 Wallace et al. Mar 1999 A
5882348 Winterton et al. Mar 1999 A
5884622 Younes Mar 1999 A
5884623 Winter Mar 1999 A
5909731 O'Mahony et al. Jun 1999 A
5915379 Wallace et al. Jun 1999 A
5915380 Wallace et al. Jun 1999 A
5915382 Power Jun 1999 A
5918597 Jones et al. Jul 1999 A
5921238 Bourdon Jul 1999 A
5931160 Gilmore et al. Aug 1999 A
5931162 Christian Aug 1999 A
5934274 Merrick et al. Aug 1999 A
5937853 Strom Aug 1999 A
5937854 Stenzler Aug 1999 A
6013619 Cochrane et al. Jan 2000 A
6024089 Wallace et al. Feb 2000 A
6029664 Zdrojkowski et al. Feb 2000 A
6041780 Richard et al. Mar 2000 A
6047860 Sanders Apr 2000 A
6076523 Jones et al. Jun 2000 A
6086529 Arndt Jul 2000 A
6099481 Daniels et al. Aug 2000 A
6105572 Shaffer et al. Aug 2000 A
6116240 Merrick et al. Sep 2000 A
6116464 Sanders Sep 2000 A
6123073 Schlawin et al. Sep 2000 A
6131571 Lampotang et al. Oct 2000 A
6135106 Dirks et al. Oct 2000 A
6142150 O'Mahony et al. Nov 2000 A
6148814 Clemmer et al. Nov 2000 A
6155257 Lurie et al. Dec 2000 A
6158432 Biondi et al. Dec 2000 A
6158433 Ong Dec 2000 A
6161539 Winter Dec 2000 A
6179784 Daniels et al. Jan 2001 B1
6220245 Takabayashi et al. Apr 2001 B1
6240920 Strom Jun 2001 B1
6257234 Sun Jul 2001 B1
6269812 Wallace et al. Aug 2001 B1
6273088 Hillsman Aug 2001 B1
6273444 Power Aug 2001 B1
6283119 Bourdon Sep 2001 B1
6296630 Altman et al. Oct 2001 B1
6305373 Wallace et al. Oct 2001 B1
6305374 Zdrojkowski et al. Oct 2001 B1
6306099 Morris Oct 2001 B1
6321748 O'Mahoney Nov 2001 B1
6325785 Babkes et al. Dec 2001 B1
6354294 Villareal, Jr. Mar 2002 B1
6355002 Faram et al. Mar 2002 B1
6357438 Hansen Mar 2002 B1
6360740 Ward et al. Mar 2002 B1
6360745 Wallace et al. Mar 2002 B1
6369838 Wallace et al. Apr 2002 B1
6371113 Tobia et al. Apr 2002 B1
6390091 Banner et al. May 2002 B1
6412483 Jones et al. Jul 2002 B1
6439229 Du et al. Aug 2002 B1
6463930 Biondi et al. Oct 2002 B2
6467478 Merrick et al. Oct 2002 B1
6470888 Matter Oct 2002 B1
6512938 Claure et al. Jan 2003 B2
6526970 DeVries et al. Mar 2003 B2
6539940 Zdrojkowski et al. Apr 2003 B2
6543449 Woodring et al. Apr 2003 B1
6546930 Emerson et al. Apr 2003 B1
6553991 Isaza Apr 2003 B1
6557553 Borrello May 2003 B1
6571795 Bourdon Jun 2003 B2
6584973 Biondi et al. Jul 2003 B1
6615824 Power Sep 2003 B2
6622726 Du Sep 2003 B1
6626843 Hillsman Sep 2003 B2
6629934 Mault et al. Oct 2003 B2
6631716 Robinson et al. Oct 2003 B1
6644310 Delache et al. Nov 2003 B1
6655382 Kolobow Dec 2003 B1
6662032 Gavish et al. Dec 2003 B1
6668824 Isaza et al. Dec 2003 B1
6668829 Biondi et al. Dec 2003 B2
6671529 Claure Dec 2003 B2
6672300 Grant Jan 2004 B1
6675801 Wallace et al. Jan 2004 B2
6718974 Moberg Apr 2004 B1
6725447 Gilman et al. Apr 2004 B1
6729326 Winterton et al. May 2004 B1
6739337 Isaza May 2004 B2
6761165 Strickland, Jr. Jul 2004 B2
6761167 Nadjafizadeh et al. Jul 2004 B1
6761168 Nadjafizadeh et al. Jul 2004 B1
6776156 Lurie Aug 2004 B2
6796305 Banner et al. Sep 2004 B1
6804656 Rosenfeld et al. Oct 2004 B1
6810876 Berthon-Jones Nov 2004 B2
6814074 Nadjafizadeh et al. Nov 2004 B1
6817363 Biondi et al. Nov 2004 B2
6820618 Banner et al. Nov 2004 B2
6866040 Bourdon Mar 2005 B1
6877511 DeVries et al. Apr 2005 B2
6935336 Lurie et al. Aug 2005 B2
6948497 Zdrojkowski et al. Sep 2005 B2
6960854 Nadjafizadeh et al. Nov 2005 B2
6983749 Kumar et al. Jan 2006 B2
7017574 Biondi et al. Mar 2006 B2
7036504 Wallace et al. May 2006 B2
7056334 Lennox Jun 2006 B2
7066173 Banner et al. Jun 2006 B2
7077131 Hansen Jul 2006 B2
RE39225 Isaza et al. Aug 2006 E
7086402 Peterson Aug 2006 B2
7100607 Zdrojkowski et al. Sep 2006 B2
7117438 Wallace et al. Oct 2006 B2
7210478 Banner et al. May 2007 B2
7222623 DeVries et al. May 2007 B2
7246618 Habashi Jul 2007 B2
7258120 Melker Aug 2007 B2
7270126 Wallace et al. Sep 2007 B2
7314449 Pfeiffer et al. Jan 2008 B2
7320321 Pranger et al. Jan 2008 B2
7325545 Dellaca' et al. Feb 2008 B2
7334578 Biondi et al. Feb 2008 B2
7341058 Halbert Mar 2008 B2
7341061 Wood Mar 2008 B2
7347205 Levi Mar 2008 B2
7364553 Paz et al. Apr 2008 B2
7367335 Fuhrman et al. May 2008 B2
7369757 Farbarik May 2008 B2
7370650 Nadjafizadeh et al. May 2008 B2
7395216 Rosenfeld et al. Jul 2008 B2
7425201 Euliano et al. Sep 2008 B2
7428902 Du et al. Sep 2008 B2
7433732 Carney et al. Oct 2008 B1
7433827 Rosenfeld et al. Oct 2008 B2
7454359 Rosenfeld et al. Nov 2008 B2
7460959 Jafari Dec 2008 B2
7487773 Li Feb 2009 B2
7487778 Freitag Feb 2009 B2
7654802 Crawford, Jr. et al. Feb 2010 B2
7694677 Tang Apr 2010 B2
7717113 Andrieux May 2010 B2
7784461 Figueiredo et al. Aug 2010 B2
7823588 Hansen Nov 2010 B2
7855716 McCreary et al. Dec 2010 B2
D632796 Ross et al. Feb 2011 S
D632797 Ross et al. Feb 2011 S
7891354 Farbarik Feb 2011 B2
7893560 Carter Feb 2011 B2
7984714 Hausmann et al. Jul 2011 B2
7992557 Nadjafizadeh et al. Aug 2011 B2
8001967 Wallace et al. Aug 2011 B2
8021310 Sanborn et al. Sep 2011 B2
8181648 Perine et al. May 2012 B2
8210173 Vandine Jul 2012 B2
8210174 Farbarik Jul 2012 B2
8267085 Jafari et al. Sep 2012 B2
8272379 Jafari et al. Sep 2012 B2
8272380 Jafari et al. Sep 2012 B2
8302600 Andrieux et al. Nov 2012 B2
8302602 Andrieux et al. Nov 2012 B2
20020022823 Luo et al. Feb 2002 A1
20020026941 Biondi et al. Mar 2002 A1
20020032430 Luo et al. Mar 2002 A1
20020091309 Auer Jul 2002 A1
20030140921 Smith et al. Jul 2003 A1
20040000314 Angel Jan 2004 A1
20040077934 Massad Apr 2004 A1
20040081580 Hole et al. Apr 2004 A1
20040231664 Lurie et al. Nov 2004 A1
20050005936 Wondka Jan 2005 A1
20050034725 Stromberg et al. Feb 2005 A1
20050039748 Andrieux Feb 2005 A1
20050109340 Tehrani May 2005 A1
20050121038 Christopher Jun 2005 A1
20050133027 Elaz et al. Jun 2005 A1
20050139212 Bourdon Jun 2005 A1
20050150494 DeVries et al. Jul 2005 A1
20050154368 Lim et al. Jul 2005 A1
20050205093 Jabour et al. Sep 2005 A1
20050217666 Fink et al. Oct 2005 A1
20050217671 Fisher et al. Oct 2005 A1
20060065270 Li Mar 2006 A1
20060089539 Miodownik et al. Apr 2006 A1
20060107962 Ward et al. May 2006 A1
20060174884 Habashi Aug 2006 A1
20060201507 Breen Sep 2006 A1
20060249156 Moretti Nov 2006 A1
20060271409 Rosenfeld et al. Nov 2006 A1
20070017515 Wallace et al. Jan 2007 A1
20070021808 Rojas Jan 2007 A1
20070023036 Grychowski et al. Feb 2007 A1
20070068518 Urias et al. Mar 2007 A1
20070077200 Baker Apr 2007 A1
20070123785 Lu et al. May 2007 A1
20070129666 Barton et al. Jun 2007 A1
20070144521 DeVries et al. Jun 2007 A1
20070162097 Rojas Jul 2007 A9
20070181122 Mulier Aug 2007 A1
20070186928 Be'Eri Aug 2007 A1
20070199566 Be'eri Aug 2007 A1
20070227537 Bemister et al. Oct 2007 A1
20070227538 Scholler et al. Oct 2007 A1
20070255159 Tham et al. Nov 2007 A1
20070274693 Farbarik Nov 2007 A1
20070284361 Nadjafizadeh et al. Dec 2007 A1
20080009761 Acker et al. Jan 2008 A1
20080011301 Qian Jan 2008 A1
20080041371 Freitag Feb 2008 A1
20080041381 Tham et al. Feb 2008 A1
20080053441 Gottlib et al. Mar 2008 A1
20080066746 Nelson et al. Mar 2008 A1
20080066753 Martin et al. Mar 2008 A1
20080072896 Setzer et al. Mar 2008 A1
20080072901 Habashi Mar 2008 A1
20080072902 Setzer et al. Mar 2008 A1
20080078390 Milne et al. Apr 2008 A1
20080083644 Janbakhsh et al. Apr 2008 A1
20080092894 Nicolazzi et al. Apr 2008 A1
20080097234 Nicolazzi et al. Apr 2008 A1
20080110461 MulQueeny et al. May 2008 A1
20080125828 Ignagni et al. May 2008 A1
20080135044 Freitag et al. Jun 2008 A1
20080178880 Christopher Jul 2008 A1
20080196720 Kollmeyer et al. Aug 2008 A1
20080214947 Hunt et al. Sep 2008 A1
20080230065 Heinonen Sep 2008 A1
20080236582 Tehrani Oct 2008 A1
20080295839 Habashi Dec 2008 A1
20080295840 Glaw Dec 2008 A1
20090165795 Nadjafizadeh et al. Jul 2009 A1
20090171176 Andersohn Jul 2009 A1
20090205661 Stephenson et al. Aug 2009 A1
20090205663 Vandine et al. Aug 2009 A1
20090241952 Nicolazzi et al. Oct 2009 A1
20090241953 Vandine et al. Oct 2009 A1
20090241956 Baker, Jr. et al. Oct 2009 A1
20090241957 Baker, Jr. Oct 2009 A1
20090241958 Baker, Jr. Oct 2009 A1
20090241962 Jafari et al. Oct 2009 A1
20090247891 Wood Oct 2009 A1
20090301486 Masic Dec 2009 A1
20090301487 Masic Dec 2009 A1
20090301490 Masic Dec 2009 A1
20090301491 Masic et al. Dec 2009 A1
20100011307 Desfossez et al. Jan 2010 A1
20100024820 Bourdon Feb 2010 A1
20100051026 Graboi Mar 2010 A1
20100051029 Jafari et al. Mar 2010 A1
20100069761 Karst et al. Mar 2010 A1
20100071689 Thiessen Mar 2010 A1
20100071692 Porges Mar 2010 A1
20100071695 Thiessen Mar 2010 A1
20100071696 Jafari Mar 2010 A1
20100078017 Andrieux et al. Apr 2010 A1
20100078026 Andrieux et al. Apr 2010 A1
20100081119 Jafari et al. Apr 2010 A1
20100081955 Wood, Jr. et al. Apr 2010 A1
20100139660 Adahan Jun 2010 A1
20100147303 Jafari et al. Jun 2010 A1
20100218765 Jafari et al. Sep 2010 A1
20100218766 Milne Sep 2010 A1
20100218767 Jafari et al. Sep 2010 A1
20100236555 Jafari et al. Sep 2010 A1
20100242961 Mougel et al. Sep 2010 A1
20100288283 Campbell et al. Nov 2010 A1
20100300446 Nicolazzi et al. Dec 2010 A1
20110011400 Gentner et al. Jan 2011 A1
20110023879 Vandine et al. Feb 2011 A1
20110041849 Chen et al. Feb 2011 A1
20110259330 Jafari et al. Oct 2011 A1
Foreign Referenced Citations (1)
Number Date Country
1269914 Jan 2003 EP
Non-Patent Literature Citations (5)
Entry
International Search Report re: PCT-US09-058252, mailed Dec. 17, 2009.
7200 Series Ventilator, Options, and Accessories: Operators Manual. Nellcor Puritan Bennett, Part No. 22300 A, Sep. 1990, pp. 1-196.
7200 Ventilatory System: Addendum/Errata. Nellcor Puritan Bennett, Part No. 4-023576-00, Rev. A, Apr. 1998, pp. 1-32.
800 Operator's and Technical Reference Manual. Series Ventilator System, Nellcor Puritan Bennett, Part No. 4-070088-00, Rev. L, Aug. 2010, pp. 1-476.
840 Operator's and Technical Reference Manual. Ventilator System, Nellcor Puritan Bennett, Part No. 4-075609-00, Rev. G, Oct. 2006, pp. 1-424.
Related Publications (1)
Number Date Country
20100071697 A1 Mar 2010 US
Provisional Applications (1)
Number Date Country
61100212 Sep 2008 US